Patents by Inventor Solenn LE-GUENNEC

Solenn LE-GUENNEC has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11939390
    Abstract: The present disclosure provides methods for treating multiple myeloma (such as refractory multiple myeloma or relapsed and refractory multiple myeloma) in an individual who received at least two prior therapies for multiple myeloma. The methods comprise administering to the individual an anti-CD38 antibody, pomalidomide, and dexamethasone. Also provided are methods of improving renal impairment in an individual having multiple myeloma.
    Type: Grant
    Filed: January 28, 2020
    Date of Patent: March 26, 2024
    Assignee: Sanofi-Aventis U.S. LLC
    Inventors: Heloise Audat, Audrey Bonestebe, Frank Campana Zambrano, Sylvain Huille, Solenn Le-Guennec, Lucie Manache-Alberici
  • Publication number: 20200239589
    Abstract: The present disclosure provides methods for treating multiple myeloma (such as refractory multiple myeloma or relapsed and refractory multiple myeloma) in an individual who received at least two prior therapies for multiple myeloma. The methods comprise administering to the individual an anti-CD38 antibody, pomalidomide, and dexamethasone. Also provided are methods of improving renal impairment in an individual having multiple myeloma.
    Type: Application
    Filed: January 28, 2020
    Publication date: July 30, 2020
    Inventors: Heloise AUDAT, Audrey BONESTEBE, Frank CAMPANA ZAMBRANO, Sylvain HUILLE, Solenn LE-GUENNEC, Lucie MANACHE-ALBERICI